[Medical News] 'AT-Patch' manufactured by ATsens Co., Ltd. has been approved by the Japanese PMDA (PMDA; Pharmaceuticals and Medical Devices Agency)

2022.10.04

- Entry into the Japanese market with the approval of PMDA and the application of Japanese health insurance fees 

- Aim for follow-up ECG tests after ablation treatment for atrial fibrillation 

- Plan to expand target diseases and facilities such as health checkups, arrhythmia detection

- Sales projection of $ approximately 19.4 million (27.8 billion won) over 5 years in the Japanese market